Searched for
GLOBAL OBESITY DRUG SALES
Telangana bets big on drug discovery hubTelangana is gearing up to elevate Hyderabad's pharmaceutical standing beyond manufacturing. The state is fostering an integrated ecosystem...
Madhya Pradesh High Court grants bail to two in Chhindwara toxic cough syrup caseTwo medical representatives, arrested in connection with last year's deadly toxic cough syrup case in Chhindwara that claimed over 20 young...
Telangana plans drug discovery push to move Hyderabad up pharma value chainTelangana is charting a new course to elevate Hyderabad into a global drug discovery hub. The state is fostering an integrated ecosystem by...
Nestle to cut artificial colourings from all products by end-2026Nestle is set to eliminate all artificial food colorings globally by the end of 2026, a significant move by the major food producer. This i...
'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...
Toyota sales fall for fourth month in May as declines in China, US and Middle East weighToyota Motor Company experienced a 7.2% drop in global vehicle sales for May, reflecting a fourth straight month of downfall. This slump st...
'Pan masala, gutka will be banned if even traces of intoxicants found': Karnataka CM DK ShivakumarKarnataka Chief Minister DK Shivakumar has issued a strong warning against the sale of pan masala and gutka mixed with intoxicating substan...
Karnataka: Chief Minister Shivakumar warns gutkha industry of ban if substances are foundKarnataka Chief Minister D K Shivakumar has warned the pan masala and gutkha industry of an outright ban if any intoxicating substances are...
Myanmar overtakes Afghanistan as top illicit opium source; NCB flags India riskMyanmar has become the world's top source of illicit opium, surpassing Afghanistan due to its ongoing civil war and economic crisis. This s...
Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
CDSCO asks states, port offices to step up screening to curb imports of illegal drugsIndia's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...
Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...